SPONSORED – Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, ...

Cantargia (Cantargia AB); (Nasdaq Stockholm:CANTA) today announced new clinical results from two nadunolimab combination ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

Research shows neuropathy can be more severe and more common in Black breast cancer patients, causing doctors to dial back ...

Diabetic peripheral neuropathy, which affects about 30% of diabetics, can cause numbness, tingling, or burning in the feet.

(Alliance News) - AstraZeneca PLC on Monday said its Wainzua treatment has been been recommended for EU approval to treat ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

Pharma titan AstraZeneca has announced that its Wainzua nerve damage treatment has been recommended for approval in the EU.

Parsonage-Turner syndrome following monkeypox infection is a rare form of peripheral neuropathy seen in orthopaedic practice ...

AstraZeneca and Ionis' drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating ...